Brooke Willis, PPLA

The Pharmaceutical Printed Literature Association (PPLA) raises concerns about the FDA’s proposed rule to move Patient Medication Information (PMI) to a digital-only format, potentially harming rural patients’ access to essential health information due to limited broadband access.

The Pharmaceutical Printed Literature Association (PPLA) advocates for the Patients’ Right to Know Their Medication Act (H.R. 1173), ensuring patients receive essential printed medication information. This is crucial for older, rural, and low-income individuals who may face challenges accessing digital information, ultimately improving health outcomes for Americans.

Healthcare experts criticize the FDA’s proposal to digitize printed Patient Medication Information, citing concerns about accessibility, medication non-adherence, and strain on local pharmacies. Lawmakers have introduced the Patients’ Right to Know Their Medication Act (H.R. 1173) to address these issues.

The Pharmaceutical Printed Literature Association (PPLA) is advocating for the Patients’ Right to Know Their Medication Act (H.R. 1173), with strong bipartisan Congressional support. The bill aims to ensure patients have access to printed Patient Medication Information (PMI) with FDA-approved content, resisting a proposed FDA rule to digitize PMI, which could hinder access for rural and low-income patients.

The Pharmaceutical Printed Literature Association (PPLA) opposes the FDA’s rule lowering access to printed Patient Medication Information (PMI) due to its potential negative impact. The rule would shift PMI to digital format, raising concerns about access and cost. The PPLA advocates for the bipartisan Patients’ Right to Know Their Medication Act to standardize PMI based on scientific design.

The Pharmaceutical Printed Literature Association (PPLA) highlighted bipartisan Congressional support for the Patients’ Right to Know Their Medication Act (H.R. 1173). This legislation aims to protect patients’ access to printed Patient Medication Information (PMI), which is crucial for medication adherence. The bill requires standardized printed PMI approved by the FDA and opposes a proposed rule to move PMI to digital formats, emphasizing the importance of printed information accessibility.

Congressman Jared Golden reintroduced the Patients’ Right to Know Their Medication Act, requiring drug manufacturers to include printed inserts with medication information to ensure rural Americans and seniors have access to vital details. This aims to support rural residents, seniors, and the local job market.

Two Sides North America welcomes the Pharmaceutical Printed Literature Association (PPLA) as a new member. PPLA advocates for printed medical information, supporting patient safety and environmental responsibility in medication communication.

The Association of Mature American Citizens (AMAC) supports the Patients’ Right to Know Their Medication Act, advocating for clear and standardized prescription medication information to empower seniors and improve health outcomes, urging Congressmen Golden and Carter to take action.